PROCAINAMIDE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Procainamide Hydrochloride patents expire, and when can generic versions of Procainamide Hydrochloride launch?
Procainamide Hydrochloride is a drug marketed by Ani Pharms, Ascot, Ivax Sub Teva Pharms, Lannett, Lederle, Roxane, Vangard, Watson Labs, Abraxis Pharm, Gland Pharma Ltd, Hikma, Hospira, Intl Medication, Nexus, Pharmafair, Smith And Nephew, Solopak, Warner Chilcott, West-ward Pharms Int, Inwood Labs, and Sandoz. and is included in fifty-nine NDAs.
The generic ingredient in PROCAINAMIDE HYDROCHLORIDE is procainamide hydrochloride. There are nine drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the procainamide hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Procainamide Hydrochloride
A generic version of PROCAINAMIDE HYDROCHLORIDE was approved as procainamide hydrochloride by INTL MEDICATION on July 31st, 1984.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROCAINAMIDE HYDROCHLORIDE?
- What are the global sales for PROCAINAMIDE HYDROCHLORIDE?
- What is Average Wholesale Price for PROCAINAMIDE HYDROCHLORIDE?
Summary for PROCAINAMIDE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 21 |
| NDAs: | 59 |
| Finished Product Suppliers / Packagers: | 7 |
| Raw Ingredient (Bulk) Api Vendors: | 119 |
| Clinical Trials: | 16 |
| Patent Applications: | 1,256 |
| DailyMed Link: | PROCAINAMIDE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for PROCAINAMIDE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Abant Izzet Baysal University | N/A |
| Jeffrey Moak | Phase 4 |
| Ottawa Hospital Research Institute | Phase 4 |
Pharmacology for PROCAINAMIDE HYDROCHLORIDE
| Drug Class | Antiarrhythmic |
Medical Subject Heading (MeSH) Categories for PROCAINAMIDE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for PROCAINAMIDE HYDROCHLORIDE
US Patents and Regulatory Information for PROCAINAMIDE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Smith And Nephew | PROCAINAMIDE HYDROCHLORIDE | procainamide hydrochloride | INJECTABLE;INJECTION | 088530-001 | Mar 4, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira | PROCAINAMIDE HYDROCHLORIDE | procainamide hydrochloride | INJECTABLE;INJECTION | 089069-001 | Feb 12, 1986 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Ani Pharms | PROCAINAMIDE HYDROCHLORIDE | procainamide hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 040111-001 | Dec 13, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | PROCAINAMIDE HYDROCHLORIDE | procainamide hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 088533-001 | Dec 3, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Warner Chilcott | PROCAINAMIDE HYDROCHLORIDE | procainamide hydrochloride | INJECTABLE;INJECTION | 089529-001 | May 3, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
